发明名称 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND
摘要 <p>Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, having superior monoacylglycerol acyltransferase-2 inhibitory activity. In formula (I), ring (A) represents a partially saturated heteroaryl group, an aryl group, or a heteroaryl group; RB represents a C4-18 alkyl group, a C3-8 cycloalkyl group, a partially saturated aryl group, an aryl group, or formula (II) (in formula (II), V represents the formula -CR11R12-, the formula -CO-, the formula -CO-O-, or the formula -CO-NH-; W represents a single bond or a C1-3 alkylene group; and the ring (B) represents a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a partially saturated heteroaryl group, a saturated heterocyclyl group, an aryl group, or a heteroaryl group); Y represents a nitrogen atom or formula N+(RF); RF represents a C1-4 alkyl group; and m and n may be the same or different and each independently represent an integer 0 or 1.</p>
申请公布号 WO2012124744(A1) 申请公布日期 2012.09.20
申请号 WO2012JP56600 申请日期 2012.03.14
申请人 TAISHO PHARMACEUTICAL CO., LTD.;BUSUJIMA, TSUYOSHI;OI, TAKAHIRO;TANAKA, HIROAKI;SHIRASAKI, YOSHIHISA;IWAKIRI, KANAKO;SATO, NAGAAKI;TOKITA, SHIGERU 发明人 BUSUJIMA, TSUYOSHI;OI, TAKAHIRO;TANAKA, HIROAKI;SHIRASAKI, YOSHIHISA;IWAKIRI, KANAKO;SATO, NAGAAKI;TOKITA, SHIGERU
分类号 C07D209/44;A61K31/4035;A61K31/454;A61K31/472;A61K31/4725;A61K31/497;A61K31/498;A61K31/506;A61K31/538;A61K31/55;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P43/00;C07D217/04;C07D217/06;C07D217/22;C07D223/16;C07D401/06;C07D401/10;C07D401/12;C07D403/12;C07D405/06;C07D405/12;C07D413/12;C07D417/06 主分类号 C07D209/44
代理机构 代理人
主权项
地址